Deuterium MRS(I) has emerged as a novel metabolic imaging method. However, the deuterium labeled substrate such as [6,6’-2H2]glucose is expensive, which becomes one of the obstacles for the clinical translation of this technique. Recently, we developed a cost-effective synthesis route for a new deuterated compound [2,3,4,6,6’-2H5]glucose. The cost of [2,3,4,6,6’-2H5]glucose is significantly lower than the [6,6’-2H2]glucose. In this study, we demonstrate that this new compound can measure the glycolytic flux through a rat glioma model.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords